Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,730,220
-$280,009 QoQ
Shares Held
1,233,082
+9.8% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 164 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $1,286,079,316 across 16 Drug Manufacturers - General names. GRFS ranks #13 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
399,953 | $479,715,664 | |
| 2 | JNJ |
Johnson & Johnson
|
793,471 | $201,517,828 | |
| 3 | ABBV |
AbbVie Inc.
|
585,879 | $147,430,590 | |
| 4 | MRK |
Merck & Co., Inc.
|
932,100 | $119,774,849 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
545,861 | $68,964,077 | |
| 6 | AMGN |
Amgen Inc
|
178,875 | $64,774,213 | |
| 7 | PFE |
Pfizer Inc
|
1,971,885 | $47,482,989 | |
| 8 | AZN |
Astrazeneca PLC
|
248,108 | $47,046,238 |
All Filings in GRFS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,730,220 | 1,233,082 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,010,229 | 1,123,470 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $183,306 | 24,638 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $146,520 | 16,500 | Shares | Sole | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||